Thus, while CD48+ B-EBV and lymphoma B-cells devoid of NKG2D and DNAM-1 ligands were resistant to lysis, the preferential usage of these receptors allowed XLP-1 NK cells to kill lymphomas that expressed sufficient amounts of the specific ligands (57). This evidence concerns the gene CD48 and lymphoma.